Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo
about
Genetically Engineered Phages: a Review of Advances over the Last DecadeA chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening methodGMEnzy: a genetically modified enzybiotic databaseCharacterization of a novel cell wall binding domain-containing Staphylococcus aureus endolysin LysSA97.Engineered bacteriophage lysins as novel anti-infectivesDegradation of methicillin-resistant Staphylococcus aureus biofilms using a chimeric lysin.Construction of a chimeric lysin Ply187N-V12C with extended lytic activity against staphylococci and streptococciBacteriophage PBC1 and its endolysin as an antimicrobial agent against Bacillus cereus.A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus.Phage lytic enzymes: a history.Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.A novel endolysin disrupts Streptococcus suis with high efficiency.EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.
P2860
Q26744156-326CCA90-7885-4B4F-82A4-51894685ADFDQ27304933-0F8D2D92-0421-4FB1-A84B-03D24057263DQ28541518-0417C53D-BE04-4947-A690-34F91C4FD32CQ30008879-88C78806-A176-4144-A6B1-F8B1FF176814Q34349552-56F7B660-1EB8-4FF1-B05A-6064FE623A34Q35151246-7DAFAC5F-E8DB-4B95-B0A2-24C33A2F2F5DQ35158325-FB4B8431-1CAA-4CD7-B2EF-F290D01EA71BQ35172146-05E57F81-54CA-45AA-923F-C9F75CC43A12Q37571286-C01BE674-4F3B-4BD8-9A36-F10C50C7A4D8Q38348307-C6D416CC-895D-4046-B95C-EF0AA91B7ED8Q38537430-8ED17B4B-A361-4A12-B4EF-E8785D41DCA2Q39029801-C54B1126-E904-4F81-AAD5-D56CD26BE411Q40075857-3B6020BB-2BB8-40CC-883D-6204D9B6B168Q40327769-8094D672-C1DA-4872-A371-2F07895D112CQ41457130-F2C087E1-EA8A-4800-8326-AADF776604CCQ41484356-A3BEC15A-F0DB-4B8D-B78E-2FA947A4BD0EQ46251747-7E664137-2571-41E9-B5F1-4271C27E8244Q52642775-3A1C4E48-78A2-4866-A152-51C2A762F55A
P2860
Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Novel chimeric lysin with high ...... us aureus in vitro and in vivo
@en
Novel chimeric lysin with high ...... s aureus in vitro and in vivo.
@nl
type
label
Novel chimeric lysin with high ...... us aureus in vitro and in vivo
@en
Novel chimeric lysin with high ...... s aureus in vitro and in vivo.
@nl
prefLabel
Novel chimeric lysin with high ...... us aureus in vitro and in vivo
@en
Novel chimeric lysin with high ...... s aureus in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Novel chimeric lysin with high ...... us aureus in vitro and in vivo
@en
P2093
Hongping Wei
Junping Yu
Xian-En Zhang
Yanling Huang
P2860
P304
P356
10.1128/AAC.01793-13
P407
P577
2013-11-04T00:00:00Z